DASA extends biosensing competition deadline
The UK Defence and Science Accelerator (DASA) has extended its deadline for submissions to a biosensing competition which seeks to find innovative new proposals for technology which will enhance the British Army’s ability to detect biological agents.
Proposals for Phase 2 of the competition will be accepted by organisations which did not participate in the first phase but their ideas must be at least Technology Readiness Level (TRL) 3.
Submissions for Phase 2 of the competition were originally to be completed by 1 June; however, this has now been extended until 15 June at midday BST. Approximately £700,000 ($861,633) has been allocated by DASA to support this stage of the competition. No official explanation for the extension was given but it is likely that DASA has decided to give extra time to companies which may have experienced disruption as a result of the coronavirus pandemic.
As part of our promise to deliver comprehensive coverage to Premium News subscribers, our curated defence news content provides the latest industry updates, contract awards and programme milestones.
More from Defence Notes
-
NATO signs agreements worth billions of dollars on missiles, air defence and aircraft
Announcements on aircraft deals and agreements for trans-alliance cooperation to boost the production and purchase of weapons and equipment were key takeaways from this week’s NATO summit.
-
Ukraine experience forces rethink of counter-UAS doctrine
A panel session at Eurosatory 2026 brought together industry, academia and the French armed forces to assess how Ukraine’s battlefield reality is reshaping counter-UAS (CUAS) technology, air defence doctrine and Western procurement priorities.
-
Raytheon fast-tracks AIM-9X Sidewinder production targeting 2,500 missiles a year by 2027
RTX Raytheon is accelerating production of the AIM-9X Sidewinder, aiming to reach 2,500 missiles annually by late 2027 while strengthening its supply chain following two US Navy major contracts worth more than $2.2 billion.